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Abstract 
 
The study objective was to evaluate long acting reversible contraceptive (LARC) method 
availability and access for adolescents in rural and urban counties in West Virginia (WV).  A 
cross-sectional survey of Title X family planning providers throughout WV was conducted from 
January 2016 to July 2017.  This survey was sent to 226 family planning providers in WV to 
assess patterns of LARC availability. The survey assessed provider training level, LARC 
services provided and frequency, clinical practice, referral patterns, and comfort level providing 
adolescent LARC services.  Survey results were analyzed by providers’ rural vs urban status, 
based on US census county codes. Survey responses yielded 127 total responders, 65 (51.2%) 
were urban, and the remaining 62 (48.8%), were rural.  Urban providers had a larger 
representation of medical doctors, while rural providers were primarily nurse practitioners 
(p<0.001).  Intrauterine devices (IUD) had lower availability with rural providers (p<0.006). 
Years of experience doing IUD placement (p<0.010), frequency of placing implants (p<0.010), 
and frequency placing implants in teenagers (p<0.012) were significantly less in rural providers. 
This survey showed significant differences in practice between urban and rural settings including 
training, experience, contraceptive options, barriers to care, and practice guidelines.  
 
Keywords 
 
adolescent pregnancy, long active reversible contraceptives, rural, intrauterine devices (IUD), 
subdermal contraceptive implant 
 
Introduction 
 
Nearly half of the 6.7 million pregnancies reported in the United States each year are unintended, 
and this rate is even higher among 15-19 year old women (82%).1 West Virginia ranks 43rd out 
of the 50 states in teen birth rate, with a rate of 29.3 births per 1000 girls age 15-19 in 2016.  
This rate is down 8% from 2015, and WV ranks 24th nationally in positive change in teen birth 
rate.2 Despite this decrease, disparities exist between pregnancy rates in urban and rural 
counties.3 
 
The effectiveness of long-acting reversible contraceptives (LARCs), which include both 
intrauterine devices (IUDs) and subdermal implants, has been illustrated in many studies.  
Women who are 21 years of age and younger who use the pill, patch, or ring have almost twice 
the risk of unintended pregnancy as older women using the same methods.4 The American 
College of Obstetricians and Gynecologists recommends LARCs as first-line methods for 
contraception in the adolescent age group.5  Title X is the only federal grant program dedicated 
solely to providing individuals with comprehensive family planning and related preventive 
health services.  Title X or family planning clinics are therefore a valuable resource for women 
and adolescents seeking contraceptive care including LARCs.  IUDs and implants, however, 
require training for provision.  Depending on trained provider availability, access to these LARC 
methods may be limited in certain settings, specifically rural areas.   
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 Previous studies have assessed IUD and subdermal implant access in rural areas.  One study in a 
nationwide sample evaluated on-site availability of these methods and found that two-thirds of 
Title X family planning clinics offered IUDs, but only 36% offered on-site implants. Researchers 
concluded that smaller clinics and more rural areas may have fewer choices in contraception.6 
Another study found that Title X resources were associated with an increase use of LARC 
methods compared to non-Title X clinics when controlling for clinic size and urban/rural 
location.7 While these studies may show the advantages that Title X resources can achieve with 
LARC availability, neither evaluated family planning providers training, experience, and comfort 
levels with offering LARC services specifically to an adolescent population.  
 
Provider attitudes and training can affect the use of LARCs in rural areas.  A lack of trained 
providers along with providers that may be hesitant to perform these services in specific 
populations can also lead to underuse of these methods. One study evaluated misperceptions and 
practice patterns among Title X providers in urban and rural areas in Texas.  Providers in rural 
areas were less likely to recognize benefits of LARC contraceptives and were more cautious in 
recommending LARCs to adolescents.8 This study did not specifically survey practice patterns of 
providers trained in LARC insertion.   
 
The goal of the current study was to evaluate practice patterns of providers and availability of 
LARC services for adolescents in individual counties of WV, specifically those designated 
“rural.” Urban and rural family planning providers were compared in regard to LARC services 
offered, experience with LARC, and frequency and comfort of LARC use in adolescents.    
 
Materials and Methods 
 
This is a cross-sectional survey study evaluating availability LARCs in urban and rural counties 
in WV.  A list of Title X family planning clinics and providers were obtained from the WV 
Department of Health and Human Resources. Family planning providers contacted included 
various backgrounds in training (MD, NP, CNM and RN).  The family planning providers were 
initially contacted by email inviting them to participate in the survey study.  Two months later, 
the survey was then sent through the mail to providers that did not initially respond to the online 
survey request.  The emailed survey was conducted through the use of an online survey tool, and 
the printed copy of the survey was mailed with a prepaid return envelope.  Providers were given 
the incentive of a $20 gift card, which was mailed to providers after completing the online 
survey.  This incentive was included along with the mailed survey. Data was collected between 
June 2016 and January of 2017.     
 
The survey assessed provider age, level of training, frequency of IUD insertion in adults and 
among adolescents, frequency of implant insertion in adults and adolescents, and amount of time 
certified to provide LARC services. The survey also assessed clinical practice, referral patterns, 
and the comfort level of providing these services to adolescents assessed by a series of clinical 
vignettes. STD screening practices were also assessed with IUD use.   
 
WV counties were assigned rural and urban designations from the Rural-Urban Commuting Area 
Codes.  This is a Census based classification that utilizes the Bureau of Census Urbanized Area 
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and Urban Cluster definitions to characterize the nation's Census tracts regarding their rural and 
urban status.  Urban areas (categories 1-3) include areas with populations >50,000 people, Large 
Rural (categories 4-6) include areas with populations of 10,000-50,000 people, Small Rural 
(categories 7-9) 2,500 – 9,999, and Isolated Rural/Frontier (category 10) have less than 2,500 
people.  Counties were dichotomized into urban or rural classification using the categories 1-3 
for urban designation and 4 or greater as rural.  Urban and rural counties were compared by 
number of LARC providers per county, and differences in responses to surveyed questions on 
LARC practice. 
  
SPSS v24 was used for analysis of descriptive statistics and use of Pearson’s Chi-square test for 
assessing the categorical variables between rural and urban providers. SPSS was also used to 
conduct an analysis of variance (ANOVA) assessing for differences in means of continuous 
variables between groups.  A consent statement was included at the start of the online and mailed 
survey, and all information recorded from the survey was de-identified. Institutional review 
board approval was obtained prior to study initiation.   
 
Results 
 
A total of 226 family planning providers were contacted through a list of clinics obtained from 
the WV Department of Health and Human Resources.  Survey responses yielded 127 (56%) total 
responders, 52 (40.9%) via online and a remaining 75 (59.1%) via mail return.   Of the 
responders, 65 (51.2%) were classified as urban, and the remaining 62 (48.8%) were classified as 
rural.  Table 1 shows differences in demographics and practice patterns between the urban and 
rural providers.  Urban and rural healthcare providers did not differ significantly in age 
(p=0.291), or years of practice (p=0.154).  There was a significant difference (p<0.001) between 
providers and their level of training; MDs were the largest represented group in urban settings 
(33.8%); NPs were in rural settings (35.5%).  Providers were not significantly different in the 
number of days per week that they worked; for all providers the average was 4.40 ±1.12 days. 
The number of counties that healthcare providers practiced within was significantly different 
between rural and urban providers.  Urban providers practiced on average in 1.23 ± 0.55 
counties, compared to 1.73 ±1.16 for rural providers (p=<0.002).  
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Table 1: Demographics of healthcare providers including age, training, and years of practice.  
  Rural (N, %) Urban (N, %) p value 
Age 
 
20-29 
30-39 
40-49 
50-59 
60-69 
70-79 
Total 
 
4 (6.5%) 
21 (33.9%) 
21 (33.9%) 
9 (14.5%) 
5 (8.1%) 
2 (3.2 %) 
62 
1 (1.6%) 
20 (31.3%) 
15 (23.4%) 
15 (23.4%) 
10 (15.6%) 
3 (4.7%) 
64 
0.291 
Training 
 
RN 
NP 
PA 
MD 
DO 
CNM 
Other 
Total 
 
14 (22.6%) 
22 (35.5%) 
11 (17.7%) 
6 (9.7%) 
5 (8.1%) 
0 (0%) 
4 (6.5%) 
62 
5 (7.7%) 
21 (32.3%) 
4 (6.2%) 
22 (33.8%) 
5 (7.7%) 
7 (10.8%) 
1 (1.5%) 
65 
<0.001 
Years of 
Practice 
<5 yrs 
5-10 yrs 
11-20 yrs 
21-30 yrs 
31-40 yrs 
>40 yrs 
Total 
22 (35.5%) 
14 (22.6%) 
8 (12.9 %) 
14 (22.6%) 
2 (3.2%) 
2 (3.2%) 
62 
10 (15.4%) 
23 (35.4%) 
9 (13.8%) 
15 (23.1%) 
4 (6.2%) 
4 (6.2%) 
65 
0.154 
 
Barriers to LARC access including insurance coverage, confidentiality, provider comfort level in 
performing the procedure, transportation, and safety concerns are demonstrated in Table 2.  
Safety concerns for IUD placement was the only barrier found to be significantly different 
between rural and urban healthcare providers (p<0.007). Of healthcare providers that offer IUDs, 
rural providers responded more frequently (41.5%) that safety concerns with IUD placement was 
‘Somewhat Major’ barrier to access, while urban healthcare providers responded most frequently 
that it was a ‘Minor’ barrier to access (52.5%).   
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Table 2: Distribution of responses of healthcare providers based on their rural vs urban location 
on the severity of perceived barriers to patient IUD access. 
  Rural (N, %) Urban (N, %) P value 
Insurance 
Coverage 
 
Very minor 
Minor 
Somewhat Major 
Major 
Total 
 
20 (38.5%) 
15 (28.8%) 
6 (11.5%) 
11 (21.2%) 
52 
29 (46.8%) 
17 (27.4%) 
10 (16.1%) 
6 (9.7%) 
62 
0.334 
Confidentiality 
issues  
Very minor 
Minor 
Somewhat Major 
Major 
Total 
 
25 (47.2%) 
15 (28.3%) 
10 (18.9%) 
3 (5.7%) 
53 
30 (49.2%) 
18 (29.5%) 
12 (19.7%) 
1 (1.6%) 
61 
0.716 
Provider 
comfort level in 
performing the 
procedure  
Very minor 
Minor 
Somewhat Major 
Major 
Total 
 
17 (33.3%) 
11 (21.6%) 
11 (21.6%) 
12 (23.5%) 
51 
23 (37.7%) 
21 (34.4%) 
10 (16.4%) 
7 (11.5%) 
61 
0.209 
Transportation Very minor 
Minor 
Somewhat Major 
Major 
Total 
 
14 (26.4%) 
16 (30.2%) 
18 (34.0%) 
5 (9.4%) 
53 
14 (23.0%) 
24 (39.3%) 
17 (27.9%) 
6 (9.8%) 
61 
0.762 
Safety concerns Very minor 
Minor 
Somewhat Major 
Major 
Total 
 
16 (30.2%) 
14 (26.4%) 
22 (41.5%) 
1 (1.9%) 
53 
16 (26.2%) 
32 (52.5%) 
10 (16.4%) 
3 (4.9%) 
61 
0.007 
Having an exam Very minor 
Minor 
Somewhat Major 
Major 
Total 
14 (26.4%) 
17 (32.1%) 
19 (35.8%) 
3 (5.7%) 
53 
19 (31.1%) 
23 (37.7%) 
14 (23.0%) 
5 (8.2%) 
61 
0.500 
 
Providers were surveyed as to the various types of contraceptives offered within the family 
planning clinic where they practiced.  This included the oral contraceptive pill (OCP), patch 
(Ortho Evra®), ring (NuvaRing®), depo medroxyprogesterone acetate (DMPA), emergency 
contraception, subdermal implant (Nexplanon®), levonorgestrel intrauterine devices (Mirena®, 
Skyla®, Liletta®), and the copper IUD (Paragard®). All of the IUD contraceptive options, Mirena, 
Skyla, and Paragard, (with the exception of Liletta, which had a very low availability grossly 
(10.2%)), were offered significantly less often with rural healthcare clinics than they were with 
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urban clinics (59.7% vs 81.5%, p<0.007; 21% vs 52.3%,  p<0.001; and 45.2% vs 73.8% 
p<0.001, respectively). There were no significant differences in availability of OCPs, patch, ring, 
DMPA, EC, or subdermal implant between rural and urban clinics.   
 
LARC procedures were compared among both urban and rural providers after excluding RNs 
who in general are not trained in this procedure.  Among urban providers (MD, DO, NP, PA, 
CNM), 70% performed IUD placements, while only 50% of these rural providers performed this 
service (p<0.006). IUD availability is demonstrated in Table 3 among urban and rural providers. 
Years of experience placing IUDs were found to be significantly less (p<0.010) in rural 
providers (54.2% have <5 years experience) than in urban providers (38.1% have 5-10 years 
experience). Providers did not differ significantly in frequency of placing IUDs, or frequency of 
placing IUDs in teenagers in rural or urban settings.  
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Table 3: Frequency of IUD and implant provision among urban and rural providers. 
  Rural N (%) Urban N (%) P value 
Years doing 
IUD 
<5 yrs 
5-10 yrs 
11-15 yrs 
16-20 yrs 
21-25 yrs 
>25 yrs 
Total 
13 (54.2%) 
6 (25%) 
3 (12.5%) 
0 (0%) 
0 (0%) 
2 (8/3%) 
24 
6 (14.3%) 
16 (38.1%) 
4 (9.5%) 
4 (9.5%) 
4 (9.5%) 
8 (19%) 
42 
0.010 
Frequency of 
IUD 
Daily 
At least once weekly 
At least twice monthly 
Once monthly 
A few times per year 
Less than once yearly 
Total 
2 (8.3%) 
5 (20.8%) 
6 (25%) 
5 (20.8%) 
4 (16.7%) 
2 (8/3%) 
24 
8 (19%) 
19 (45.2%) 
5 (11.9%) 
5 (11.9%) 
4 (9.5%) 
1 (2.4%) 
42 
0.164 
Frequency of 
teen IUD 
Daily 
At least once weekly 
At least twice monthly 
Once monthly 
A few times per year 
Less than once yearly 
Total 
0 (0%) 
1 (4.2%) 
5 (20.8%) 
1 (4.2%) 
12 (50%) 
5 (20.8%) 
24 
1 (2.4%) 
4 (9.8%) 
8 (19.5%) 
5 (12.2%) 
17 (41.5%) 
6 (14.6%) 
41 
0.721 
Years doing 
Implant 
<5 yrs 
5-10 yrs 
11-15 yrs 
16-20 yrs 
21-25 yrs 
>25 yrs 
Total 
28 (71.8%) 
6 (15.4%) 
2 (5.1%) 
1 (2.6%) 
1 (2.6%) 
1 (2.6%) 
39 
18 (40.9%) 
19 (43.2%) 
3 (6.8%) 
1 (2.3%) 
3 (6.8%) 
0 (0%) 
44 
0.054 
Frequency of 
Implant 
Daily 
At least once weekly 
At least twice monthly 
Once monthly 
A few times per year 
Less than once yearly 
Total 
0 (0%) 
10 (25%) 
11 (27.5%) 
8 (20%) 
7 (27.5%) 
4 (10%) 
40 
7 (15.9%) 
17 (38.6%) 
10 (22.7%) 
3 (6.8%) 
7 (15.9%) 
0 (0%) 
44 
0.010 
Frequency of 
teen implant 
Daily 
At least once weekly 
At least twice monthly 
Once monthly 
A few times per year 
Less than once yearly 
Total 
0 (0%) 
7 (17.5%) 
4 (10%) 
8 (20%) 
15 (37.5%) 
6 (15%) 
40 
5 (11.4%) 
13 (29.5%) 
11 (25%) 
3 (6.8%) 
9 (20.5%) 
3 (6.8%) 
44 
0.012 
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STD screening protocols during IUD placement were found to be significantly different between 
urban and rural providers.  The majority of both rural and urban providers reported they would 
do the IUD insertions at the time of gonorrhea and chlamydia screening (54.2%, and 81.8%, 
respectively), however, a substantial proportion of the rural providers required screening to be 
resulted prior to insertion (37.5% vs 9% of urban providers, p=0.032). Examples of the clinical 
vignettes use to assess provider comfort with LARC insertion are shown in Table 4. No 
differences were found between urban and rural healthcare providers in their comfort level with 
the various clinical vignettes presented with different ages and parity.   
 
Table 4: Healthcare providers’ responses on their level of comfort with the listed vignettes for 
intrauterine device placement, separated by their rural vs urban classification.  
Vignette  Rural N (%) Urban N (%) P value 
An 18-year-old 
patient with prior 
pregnancy and 
delivery desires 
an intrauterine 
device insertion. 
Very uncomfortable 
Somewhat Uncomfortable 
Comfortable 
Very Comfortable 
Total 
5 (22.7%) 
0 (0%) 
4 (18.2%) 
13 (59.1%) 
22 
5 (11.6%) 
0 (0%) 
2 (4.7%) 
36 (83.7%) 
43 
0.073 
An 18-year-old 
patient who has 
never been 
pregnant desires 
an intrauterine 
device insertion. 
Very uncomfortable 
Somewhat Uncomfortable 
Comfortable 
Very Comfortable 
Total 
2 (9.1%) 
5 (22.7%) 
6 (27.3%) 
9 (40.9%) 
22 
3(7.0%) 
3 (7.0%) 
9 (20.9%) 
26 (65.1%) 
43 
0.189 
A 16-year-old 
patient who has 
never been 
pregnant desires 
an intrauterine 
device insertion. 
Very uncomfortable 
Somewhat Uncomfortable 
Comfortable 
Very Comfortable 
Total 
2 (9.1%) 
6 (27.3%) 
5 (22.7%) 
9 (40.9%) 
22 
4 (9.5%) 
4 (9.5%) 
12 (28.6%) 
22 (52.4%) 
42 
0.322 
A 13-year-old 
patient who has 
never been 
pregnant desires 
an intrauterine 
device insertion. 
Very uncomfortable 
Somewhat Uncomfortable 
Comfortable 
Very Comfortable 
Total 
7 (33.3%) 
8 (38.1%) 
2 (9.5%) 
4 (19.0%) 
21 
10 (23.3%) 
19 (44.2%) 
8 (18.6%) 
6 (14.0%) 
43 
0.650 
 
Implants were performed by 81.2% of rural providers and 73.3% of urban providers (p=0.33).  
Subdermal implant accessibility is demonstrated in Table 3 among urban and rural providers. For 
both rural and urban providers that did not perform implant insertion, referral is most commonly 
made to another provider within their facility.  For providers that offer implants, their amount of 
experience performing the procedure did not differ based on urban or rural setting.  However, 
frequency of placing subdural implants (p<0.010) and frequency placing subdermal implants in 
teenagers (p<0.012) was significantly less in rural providers than in urban providers. No 
differences were found between urban and rural healthcare providers in their comfort level with 
subdermal implant placement among the clinical vignettes (data not shown).   
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 Discussion 
 
This study supports prior studies in other states demonstrating that women in rural areas may 
have fewer contraceptive options available.6 However, the current study evaluated provider 
practice patterns with LARCs specific to an adolescent population, in whom barriers to seeking 
contraception are likely amplified.  This study demonstrated that fewer family planning clinics 
offered IUDs in rural counties in West Virginia.  Rural providers had less experience with IUD 
insertion, had more safety concerns with IUDs in adolescents, and were more likely to want STD 
testing resulted prior to IUD placement.  Safety concerns may be a reflection of level of training, 
frequency of placement, or simply lack of demand for this contraceptive method among a rural 
adolescent population.  Despite these barriers, among providers that did supply IUDs, the 
frequency of IUD placement among adolescents was not significantly different between rural and 
urban counties.   
 
With regards to implants, experience did not differ between rural and urban providers, however, 
frequency of use in adolescents was higher in urban settings.  The frequency of implant 
placement is likely a result of overall patient volume due to population density in an urban 
setting.   
 
Providers completing the survey nearly equally represented rural and urban practice settings.  
Survey methods of data collection strengthened the study by making it cost effective and allowed 
the surveillance of a large number of healthcare providers in the state of West Virginia, 
increasing the potential generalizability. However, the surveys contained categorical answer 
options and did not accommodate alternative answers. This poses a validity weakness of the 
study in its ability to completely distinguish all perspectives.  Placing all rural areas (large rural, 
small rural, and isolated) into one group is also limiting as these areas may have different 
resources.  The demand for LARC services within each area was also not assessed and could 
obviously impact frequencies and availability.  
 
Accessibility to LARC services is also affected by factors outside of the provider.  In a recent 
nationwide analysis of publicly funded family planning facilities, youth friendly practices and 
access to LARCs were analyzed.9 Accessibility to younger clients was achieved by not requiring 
scheduled appointments, having flexible hours, and providing outreach and education to younger 
patients.  These youth friendly sites had increased rates of LARC provision among younger 
clients.9 Title X has a strong commitment to the provision of contraception to adolescents, and 
Title X guidelines stress the importance of adolescent confidentiality and provision of youth 
friendly services.  However, some of these youth friendly services (flexible hours, walk in 
appointments, availability by public transport) may be inherently difficult in more rural 
locations.   
 
This study highlights possible barriers to provision of LARC services to adolescents in rural 
areas, which can be extrapolated beyond West Virginia to demographically similar regions.  Title 
X clinics remain a valuable source of contraceptive provision for women and adolescents.  
Further studies could be aimed at developing innovative strategies and resources for training 
providers in rural areas and expanding youth friendly services.    
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